Applicant, as named in the Orange Book

Merz

Next listed expiry: Inbrija on 21 Oct 2033. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Inbrija NDA 209184 levodopa	levodopa	21 Oct 2033 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Ampyra NDA 022250 dalfampridine	dalfampridine	open now no listed protection	no listed protection